Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Century Therapeutics Inc

IPSC
1,11
0,06 (5,71%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/12/202423:00EDGAR2Form 8-K - Current report
06/12/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202413:00GLOBECentury Therapeutics to Present at the Piper Sandler 36th..
05/11/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202415:10EDGAR2Form 8-K - Current report
05/11/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202415:05GLOBECentury Therapeutics Reports Third Quarter 2024 Financial..
05/11/202415:00GLOBECentury Therapeutics Announces Upcoming Poster Presentations..
04/11/202421:52EDGAR2Form 144 - Report of proposed sale of securities
04/11/202413:00GLOBECentury Therapeutics to Present at Guggenheim’s Inaugural..
26/10/202403:39EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
16/10/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/10/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202413:05EDGAR2Form 8-K - Current report
26/9/202413:00GLOBECentury Therapeutics Strengthens Leadership Team with..
08/8/202413:37EDGAR2Form 8-K - Current report
08/8/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:30GLOBECentury Therapeutics Reports Second Quarter 2024 Financial..
07/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202421:06EDGAR2Form 144 - Report of proposed sale of securities
31/7/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202423:03EDGAR2Form 144 - Report of proposed sale of securities
25/7/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202422:45EDGAR2Form 144 - Report of proposed sale of securities
23/7/202422:29EDGAR2Form 144 - Report of proposed sale of securities
08/7/202422:33EDGAR2Form 8-K - Current report
18/6/202422:49EDGAR2Form S-3 - Registration statement under Securities Act of..
10/6/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202422:19EDGAR2Form 144 - Report of proposed sale of securities
03/6/202413:13EDGAR2Form 8-K - Current report
03/6/202413:00GLOBECentury Therapeutics Presents Interim Results from Phase 1..
22/5/202414:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/5/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202418:22EDGAR2Form 144 - Report of proposed sale of securities
15/5/202422:06EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202413:00GLOBECentury Therapeutics Presents Preclinical Data Highlighting..
09/5/202413:35EDGAR2Form 8-K - Current report
09/5/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:30GLOBECentury Therapeutics Reports First Quarter 2024 Financial..
07/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:52EDGAR2Form 144 - Report of proposed sale of securities
23/4/202413:00GLOBECentury Therapeutics to Present at Chardan’s 8th Annual..
11/4/202413:00GLOBECentury Therapeutics Strengthens Position in Autoimmune..
08/4/202422:05GLOBECentury Therapeutics Presents New Preclinical Data..
Apertura: 1,05 Min: 1,045 Max: 1,12
Chiusura: 1,05

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network